It's in Your Blood.
Courts Are Just Starting
to Ask Why.
Microplastics and nanoplastics from bottled water, food packaging, and everyday plastics have been detected in human blood, organs, and tissue. Emerging research has associated exposure with cardiovascular, reproductive, and other serious health effects. There is no established mass tort yet — but filings are rising fast, and attorneys in this network are reviewing early cases now.
Litigation Status
Early Filings.
Evidence Still Developing.
Microplastics litigation is not yet a consolidated mass tort like PFAS or AFFF — there is no federal MDL, and most cases filed since 2024 have faced early dismissal. But filings have jumped sharply, and the scientific record is moving quickly. This is what an emerging, pre-MDL litigation looks like from the inside.
A review of federal and state dockets found at least 18 microplastics-related federal cases and 5 state cases filed in 2024–2025, compared with only one comparable case in the prior six years, per an American Bar Association litigation review.
No consolidated federal MDL currently exists for microplastics personal-injury claims. Most early cases — over water bottles, food packaging, and baby products — have been dismissed at the motion-to-dismiss stage on causation or preemption grounds.
Attorneys in this network evaluating microplastics cases work on contingency. No retainer, no hourly billing. If no recovery is obtained on your behalf, you owe nothing.
"The science is moving faster than the courts — for now."
What's Being Alleged & By Whom
The Exposure.
The Products.
The Evidence.
Microplastics claims rest on a growing body of human research plus specific, identifiable products — not just the general presence of plastic in the environment. A connected attorney will assess which theories, if any, fit your situation.
Cardiovascular Disease & Vascular Inflammation
A 2026 systematic review of human studies reported associations between micro/nanoplastic burden and inflammatory markers, vascular inflammation, and adverse cardiac events. Causation has not been proven in any individual case.
Reproductive Injury, Infertility & Pregnancy Complications
Human studies have associated micro/nanoplastic exposure with reduced sperm quality and findings involving placental tissue. Litigation in this area is at an early, largely untested stage.
Baby Bottles, Wipes & Developmental Concerns
Some of the earliest microplastics cases involve reusable baby bottles and baby wipes, including a California federal case alleging a "BPA Free" bottle label was misleading because the product shed microplastics. Most such cases remain unresolved or dismissed.
Cancer & Gastrointestinal / Liver Effects
Mechanistic research has identified pathways including oxidative stress, inflammation, and DNA damage from smaller particles, with some reviews discussing possible links to cancer and liver or GI disease. Direct human causal evidence remains limited.
Bottled Water & Food Packaging Manufacturers
Cases including Slowinski v. BlueTriton Brands have alleged that bottled water labeled "natural" or "spring water" misleadingly omitted the presence of microplastics; that case was dismissed, with the court citing FDA labeling authority and the prevalence of microplastics generally.
Civilian & Occupational Exposure — Textiles & Drinking Water
Beyond named-product cases, exposure through synthetic textiles, household plastics, and municipal drinking water is a developing area attorneys are tracking for viable individual claims with strong documentation.
Eligibility
What Strengthens
a Potential Claim
Because this is an emerging area of litigation, there's no fixed eligibility checklist. The strongest potential claims combine a documented diagnosis with a specific, identifiable product or exposure source — the rest is for a connected attorney to assess at no cost.
You have a documented diagnosis in a linked disease cluster
Cardiovascular disease, infertility or pregnancy complications, developmental concerns, or certain cancers diagnosed after long-term exposure are the diagnoses attorneys are currently evaluating most closely.
You used a specific, identifiable product for years
Bottled water, a particular food-storage brand, or baby products used regularly and over time — with receipts, packaging, or purchase history — meaningfully strengthens a potential exposure claim.
You worked in plastics manufacturing or synthetic textiles
Prolonged occupational exposure to plastic particles or synthetic fibers, especially with workplace air or water testing on record, is a documented exposure pathway attorneys look for.
Your drinking water source has documented microplastic testing
Municipal or private water testing showing microplastic contamination, combined with a qualifying diagnosis, can help establish a plausible exposure pathway.
You have long-term exposure through synthetic textiles or household plastics
Regular, extended contact or airborne exposure from synthetic clothing, carpeting, or household plastic products is a newer theory attorneys are still evaluating case by case.
Your diagnosis is recent, or you're still gathering documentation
Ordinary state statutes of limitation apply even though there's no MDL — typically two to three years from diagnosis. A connected attorney can flag your state's deadline and what evidence to preserve now.
How It Works
Zero Upfront.
Honest About Where Things Stand.
This is an emerging, pre-MDL area of law. Attorneys in this network will tell you plainly whether your situation looks worth pursuing — there's no guaranteed outcome, and no cost to find out.
Free Confidential Case Review
A connected attorney reviews your diagnosis alongside your exposure history — specific products, water source, occupation — and gives you an honest read on whether it's worth pursuing right now.
Exposure & Product Documentation
Receipts, product packaging, water testing, employment records, and medical records are gathered to try to tie a specific exposure source to your diagnosis — the piece courts have focused on most.
Case Evaluation & Filing, If Warranted
Because there is no consolidated MDL, viable cases are filed individually under applicable state consumer-protection or product-liability law, coordinated as the litigation landscape develops.
Resolution as the Law Develops
Outcomes here are less certain than in established mass torts. A connected attorney's fee comes only from any recovery — you pay nothing out of pocket at any stage.
From Those Who Reached Out
Their Words
"I'd been drinking the same bottled water brand for over a decade when I was diagnosed. I didn't know there was any litigation around microplastics at all — the review just helped me understand whether keeping my receipts and records was worth doing."
"My doctor mentioned microplastics research almost in passing. I wasn't looking for a lawsuit, I just wanted to know what the actual evidence said. The attorney I spoke with was upfront that this area of law is still very early."
"We used the same brand of baby bottles for both our kids. When one of our pediatric visits came back with unexpected concerns, we started looking into it. The case review didn't promise anything — it just walked us through what mattered."
Common Questions
What You Need to Know
Microplastics litigation is still emerging. There is no consolidated federal MDL yet, and most cases filed since 2024 have faced early dismissal on causation or labeling-preemption grounds. Filings have still risen sharply — from roughly one comparable case in 2018–2023 to at least 23 federal and state cases in 2024–2025. Submit your information for a free evaluation to find out where your situation stands.
Human studies have reported associations between microplastic burden and cardiovascular inflammation, reduced sperm quality, placental and pregnancy-related findings, developmental concerns, and gastrointestinal, respiratory, and certain cancer outcomes. These are associations reported in the literature, not proof of causation in any individual case. A connected attorney can discuss your specific diagnosis at no cost.
Some of the earliest microplastics cases involve single-use water bottles, baby bottles, baby wipes, and food packaging. Courts have dismissed several of these for failing to tie a specific product to a plaintiff's exposure. Documented, repeated use of a specific product meaningfully strengthens a potential claim. A connected attorney can assess your product history at no cost.
A documented diagnosis combined with a plausible, identifiable exposure source strengthens a potential claim. Because this is an emerging area of litigation, eligibility is assessed case by case rather than against a fixed list. A connected attorney can review your diagnosis and exposure history for free.
There's no MDL-wide deadline, since no MDL exists yet. Ordinary state statutes of limitation for product liability and personal injury still apply, typically two to three years from diagnosis or discovery. Contact a connected attorney to find out the deadline that applies in your state.
Microplastics and nanoplastics are plastic particles shed from bottled water, food packaging, household plastics, and synthetic textiles. The FDA has acknowledged detecting them in food and in human blood, urine, stool, and organs, while stating current evidence isn't yet sufficient to establish detected levels pose a health risk. Find out if your exposure history is worth reviewing.
PFAS and AFFF litigation involve a consolidated federal MDL, multi-billion dollar settlements, and decades of internal industry documents. Microplastics litigation has none of that yet — it's a much earlier-stage, higher-risk area of law, built on a rapidly growing but still incomplete scientific record. A connected attorney can give you an honest assessment of where a potential claim like yours currently stands.
The Evidence Is Still
Being Written.
The evaluation is free. The call is confidential. There is no obligation, and no guarantee of any outcome — this is an emerging area of law.